Pages
The latest Olympic star: Kinesio tape
Mitchell Hartman Aug 13, 2012
Olympic athletes helped increase sales of colorful therapeutic tape.
Obama administration takes initiative against health care fraud
Nancy Marshall-Genzer Jul 26, 2012
Attorney General Eric Holder and Health and Human Services Secretary Kathleen Sebelius are spearheading an effort to fight against health care fraud by teaming up with private insurers.
Who gets Medicaid and who doesn't?
Dan Gorenstein Aug 8, 2012
It's supposed to be a health care program for the poor. But over the years, the definition of poor has changed.
Australian woman wins key Thalidomide settlement
Stuart Cohen Jul 18, 2012
Today, a woman in Australia born without arms or legs reached a multi-million dollar settlement with the distributor of Thalidomide, as a previously undiagnosed victim of the drug's side effects. The case may prompt similar legal action for uncompensated victims around the world.
Drinking and divorce among the baby boomers
Mark Garrison Jul 13, 2012
More long-term marriages are breaking up and a wine habit may benefit older women's bones.
Texas opts out of key health care reform provisions
Jeff Horwich Jul 12, 2012
It's been almost two weeks since the Supreme Court ruled President Obama's health care overhaul constitutional. Today Texas Governor Rick Perry has officially announced his plans to opt out of the Medicaid expansion and insurance exchanges included in the Affordable Care Act.
WellPoint gears up for Medicaid bonanza
Dan Gorenstein Jul 9, 2012
The giant health insurer will acquire competitor Amerigroup Corp. for nearly $5 billion in a bid for more Medicaid business.
A week after Supreme Court decision, Americans still divided
Frank Newport Jul 5, 2012
It's been exactly a week since the Supreme Court announced that President Obama's healthcare overhaul is constitutional. Have Americans shifted their view of the law?
What's so bad about off-label uses of medication?
David Brancaccio Jul 3, 2012
GlaxoSmithKline, the huge British drug-maker, will pay $3 billion in fines and compensation to the U.S. government and the states. They are in trouble for marketing drugs for off-label uses of its drugs.
GlaxoSmithKline reaches $3 billion settlement for fraud
Mitchell Hartman Jul 3, 2012
GlaxoSmithKline, the huge British drug maker, will pay $3 billion in fines and compensation to the U.S. government and the states. According to the Justice Department, it's the biggest settlement in a health-care fraud case in history.
